Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    15505275 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Terminated
Has Results
Vandetanib to Treat Women With Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Conditions: Ovarian Neoplasms;   Fallopian Tube Neoplasms;   Peritoneal Neoplasms
Intervention: Drug: Vandetanib

Indicates status has not been verified in more than two years